Pharmaceutical giant Eli Lilly (LLY) surged 14% last week to $840 per share following positive Phase 3 trial results for its ...

Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

We recently published a list of the 13 Best American Dividend Stocks to Buy According to Analysts. In this article, we are ...

Novo Nordisk (NYSE: NVO) stock hit an all-time high of $148.15 in June 2024, marking a remarkable fivefold surge since 2019.

Shares of Eli Lilly LLY soared 14.3% on April 17 after data from a late-stage study showed that orforglipron achieved the ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Stock futures pointed lower Monday and Treasury yields rose as Wall Street remained on edge over President Donald Trump’s ...

Eli Lilly's stock leapt 14.5% on Friday, soaring past $840 with a trading volume explosion of 217%. Analysts from Morgan Stanley, Wells Fargo, and Goldman Sachs issued updated buy ratings, nudging ...